Latest Asx News

Morella Corporation has expanded its rubidium exploration footprint at the Mt Edon Project in Western Australia, identifying multiple new high-grade targets with assays up to 2.84% Rb2O. This development strengthens the company's position in the critical minerals sector alongside its lithium assets.

QX Resources has raised $1.23 million through a placement to fund exploration at its promising Madaba Uranium Project in Tanzania, setting the stage for a heli-borne survey and maiden drilling program this year.

IRIS Metals has raised $5.5 million through a strongly supported placement to accelerate development of its critical minerals portfolio in the United States, including early sales from its Beecher Project.

Aguia Resources has successfully raised $5 million through a well-supported placement to fund key developments in its Colombian gold and Brazilian phosphate projects. The capital injection aims to boost production and strengthen the company's balance sheet.

1414 Degrees has achieved a key milestone with its SiNTL silicon anode material reaching 500 mAh/g, matching current commercial standards ahead of schedule and setting sights on 600 mAh/g within a year.

Locksley Resources has reported outstanding high-grade antimony assay results from its Desert Antimony Mine in California, with samples reaching up to 26.1% Sb. This breakthrough supports the company’s plans for a pilot plant aimed at domestic production critical to U.S. defense needs.

Medallion Metals has obtained the crucial environmental green light under the EPBC Act for its Ravensthorpe Gold Project, significantly reducing permitting risks and positioning the company to advance its sulphide production plans.

Noronex Limited has exercised its option to acquire a 51% stake in the Etango North Uranium Project in Namibia, initiating a maiden drilling program backed by AI-driven exploration techniques.

Sparc Technologies and the Australian Institute for Machine Learning are developing AI-driven software to transform protective coatings corrosion assessment, promising faster, more accurate results for a global market of testing labs.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.

Xero Limited has outlined a bold AI strategy and detailed the integration of Melio to accelerate its US market growth, supported by new financial disclosures and a clear path to profitability.